CONTACT INFORMATION http://www.loyola.org
Kathy S. Albain
M.D.
  • Professor
  • Hematology/Oncology
Specialties
Breast Cancer, Lung Cancer, Cancer Survivorship, Cancer in Seniors, Chemoprevention of Breast Cancer, Chemoprevention of Lung Cancer, Mesothelioma
Board Certifications
  • Internal Medicine - General Cert: AM Board of Internal Medicine
  • Medical Oncology - Subspecialty Cert: AM Board of Internal Medicine
Publications

Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive, Locally Advanced, or Metastatic Breast CancerMiller,K. D.; Dieras,V.; Harbeck,N.; Andre,F.; Mahtani,R. L.; Gianni,L.; Albain,K. S.; Crivellari,D.; Fang,L.; Michelson,G.; de Haas,S. L.; Burris,H. A.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 ; ( ):

Developing Safety Criteria for Introducing New Agents into Neoadjuvant TrialsDemichele,A.; Berry,D. A.; Zujewski,J.; Hunsberger,S.; Rubinstein,L.; Tomaszewski,J. E.; Kelloff,G.; Perlmutter,J.; Buxton,M.; Lyandres,J.; Albain,K. S.; Benz,C.; Chien,A. J.; Haluska,P.; Leyland-Jones,B.; Liu,M. C.; Munster,P.; Olopade,O.; Park,J. W.; Parker,B. A.; Pusztai,L.; Tripathy,D.; Rugo,H.; Yee,D.; Esserman,L.Clinical cancer research : an official journal of the American Association for Cancer Research 2013 ;19(11):2817-2823

Supplement use during an intergroup clinical trial for breast cancer (S0221)Zirpoli,G. R.; Brennan,P. M.; Hong,C. C.; McCann,S. E.; Ciupak,G.; Davis,W.; Unger,J. M.; Budd,G. T.; Hershman,D. L.; Moore,H. C.; Stewart,J.; Isaacs,C.; Hobday,T.; Salim,M.; Hortobagyi,G. N.; Gralow,J. R.; Albain,K. S.; Ambrosone,C. B.Breast cancer research and treatment 2013 ;137(3):903-913

Patient income level and cancer clinical trial participationUnger,J. M.; Hershman,D. L.; Albain,K. S.; Moinpour,C. M.; Petersen,J. A.; Burg,K.; Crowley,J. J.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 ;31(5):536-542

Positron Emission Tomography-avid Adrenal Mass and Incidental Renal Mass in a 70-Year-Old Woman With Newly Diagnosed Breast CancerHannick,J. H.; Wang,L.; Barkan,G. A.; Perez,C.; Bova,D.; Albain,K. S.; Quek,M. L.Urology 2013 ; ( ):

Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer TherapyHershman,D. L.; Unger,J. M.; Crew,K. D.; Minasian,L. M.; Awad,D.; Moinpour,C. M.; Hansen,L.; Lew,D. L.; Greenlee,H.; Fehrenbacher,L.; Wade,J. L.,3rd; Wong,S. F.; Hortobagyi,G. N.; Meyskens,F. L.; Albain,K. S.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 ;31(20):2627-33

Combination anastrozole and fulvestrant in metastatic breast cancerMehta,R. S.; Barlow,W. E.; Albain,K. S.; Vandenberg,T. A.; Dakhil,S. R.; Tirumali,N. R.; Lew,D. L.; Hayes,D. F.; Gralow,J. R.; Livingston,R. B.; Hortobagyi,G. N.The New England journal of medicine 2012 ;367(5):435-444

Phase II Trial of Simple Oral Therapy with Capecitabine and Cyclophosphamide in Patients with Metastatic Breast Cancer: SWOG S0430Schott,A. F.; Barlow,W. E.; Albain,K. S.; Chew,H. K.; Wade,J. L.; Lanier,K. S.; Lew,D. L.; Hayes,D. F.; Gralow,J. R.; Livingston,R. B.; Hortobagyi,G. N.Oncologist 2012 ;17(2):179-188

A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316)Javid,S. H.; Unger,J. M.; Gralow,J. R.; Moinpour,C. M.; Wozniak,A. J.; Goodwin,J. W.; Lara,P. N.,Jr; Williams,P. A.; Hutchins,L. F.; Gotay,C. C.; Albain,K. S.The oncologist 2012 ;17(9):1180-1190

Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?Burstein,H. J.; Piccart-Gebhart,M. J.; Perez,E. A.; Hortobagyi,G. N.; Wolmark,N.; Albain,K. S.; Norton,L.; Winer,E. P.; Hudis,C. A.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 ;30(18):2179-2182

Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancerMoinpour,C. M.; Donaldson,G. W.; Liepa,A. M.; Melemed,A. S.; O'Shaughnessy,J.; Albain,K. S.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012 ;21(5):765-775

Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesotheliomaKindler,H. L.; Karrison,T. G.; Gandara,D. R.; Lu,C.; Krug,L. M.; Stevenson,J. P.; Janne,P. A.; Quinn,D. I.; Koczywas,M. N.; Brahmer,J. R.; Albain,K. S.; Taber,D. A.; Armato,S. G.,3rd; Vogelzang,N. J.; Chen,H. X.; Stadler,W. M.; Vokes,E. E.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 ;30(20):2509-2515

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)Sucheston,L. E.; Zhao,H.; Yao,S.; Zirpoli,G.; Liu,S.; Barlow,W. E.; Moore,H. C.; Thomas Budd,G.; Hershman,D. L.; Davis,W.; Ciupak,G. L.; Stewart,J. A.; Isaacs,C.; Hobday,T. J.; Salim,M.; Hortobagyi,G. N.; Gralow,J. R.; Livingston,R. B.; Albain,K. S.; Hayes,D. F.; Ambrosone,C. B.Breast cancer research and treatment 2011 ;130(3):993-1002

Commentary on adjuvant chemotherapy for the older woman with early stage breast cancerAlbain,K. S.Breast (Edinburgh, Scotland) 2011 ;20 Suppl 3( ):S150-2

SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancerLivingston,R. B.; Barlow,W. E.; Kash,J. J.; Albain,K. S.; Gralow,J. R.; Lew,D. L.; Flaherty,L. E.; Royce,M. E.; Hortobagyi,G. N.Breast cancer research and treatment 2011 ;130(1):123-131

Impact of Multigene Assays in Early Stage Breast CancerLo,S. S.; Albain,K. S.Oncologist 2011 ;16(11):1482-1483

Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence.Pandya,K.; Meeke,K.; Clementz,A. G.; Rogowski,A.; Roberts,J.; Miele,L.; Albain,K. S.; Osipo,C.British journal of cancer 2011 ;105(6):796-806

Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancerGervais,R.; Hainsworth,J. D.; Blais,N.; Besse,B.; Laskin,J.; Hamm,J. T.; Lipton,A.; Albain,K. S.; Masters,G. A.; Natale,R. B.; Selaru,P.; Kim,S. T.; Chao,R. C.; Page,R. D.Lung cancer (Amsterdam, Netherlands) 2011 ;74(3):474-480

Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancerYao,S.; Barlow,W. E.; Albain,K. S.; Choi,J. Y.; Zhao,H.; Livingston,R. B.; Davis,W.; Rae,J. M.; Yeh,I. T.; Hutchins,L. F.; Ravdin,P. M.; Martino,S.; Lyss,A. P.; Osborne,C. K.; Abeloff,M.; Hortobagyi,G. N.; Hayes,D. F.; Ambrosone,C. B.Clinical cancer research : an official journal of the American Association for Cancer Research 2010 ;16(24):6169-6176

Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancerYao,S.; Barlow,W. E.; Albain,K. S.; Choi,J. Y.; Zhao,H.; Livingston,R. B.; Davis,W.; Rae,J. M.; Yeh,I. T.; Hutchins,L. F.; Ravdin,P. M.; Martino,S.; Lyss,A. P.; Osborne,C. K.; Abeloff,M. D.; Hortobagyi,G. N.; Hayes,D. F.; Ambrosone,C. B.Breast cancer research and treatment 2010 ;124(2):433-439

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012)Slovak,M. L.; Bedell,V.; Lew,D.; Albain,K. S.; Ellis,G. K.; Livingston,R. B.; Martino,S.; Perez,E. A.; Hortobagyi,G. N.; Sher,D.; Stock,W.Breast cancer research and treatment 2010 ;119(2):391-398

Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342Herbst,R. S.; Kelly,K.; Chansky,K.; Mack,P. C.; Franklin,W. A.; Hirsch,F. R.; Atkins,J. N.; Dakhil,S. R.; Albain,K. S.; Kim,E. S.; Redman,M.; Crowley,J. J.; Gandara,D. R.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(31):4747-4754

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.Lo,S. S.; Mumby,P. B.; Norton,J.; Rychlik,K.; Smerage,J.; Kash,J.; Chew,H. K.; Gaynor,E. R.; Hayes,D. F.; Epstein,A.; Albain,K. S.Journal of Clinical Oncology 2010 ;28(10):1671-1676

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.Albain,K. S.; Barlow,W. E.; Shak,S.; Hortobagyi,G. N.; Livingston,R. B.; Yeh,I. T.; Ravdin,P.; Bugarini,R.; Baehner,F. L.; Davidson,N. E.; Sledge,G. W.; Winer,E. P.; Hudis,C.; Ingle,J. N.; Perez,E. A.; Pritchard,K. I.; Shepherd,L.; Gralow,J. R.; Yoshizawa,C.; Allred,D. C.; Osborne,C. K.; Hayes,D. F.Lancet Oncology 2010 ;11(1):55-65

Proceedings of the first global workshop on breast cancer: pathways to the evaluation and clinical development of novel agents for breast cancerAlbain,K. S.; Carey,L.; Gradishar,W. J.; Gralow,J. R.; Lipton,A.; Rugo,H.; Tripathy,D.; Peck,S.; Abair,T.; Pegram,M.Clinical Breast Cancer 2010 ;10(6):421-439

A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lungLeighl,N. B.; Raez,L. E.; Besse,B.; Rosen,P. J.; Barlesi,F.; Massarelli,E.; Gabrail,N.; Hart,L. L.; Albain,K. S.; Berkowitz,L.; Melnyk,O.; Shepherd,F. A.; Sternas,L.; Ackerman,J.; Shun,Z.; Miller,V. A.; Herbst,R. S.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 ;5(7):1054-1059

Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.Grudzien,P.; Lo,S.; Albain,K. S.; Robinson,P.; Rajan,P.; Strack,P. R.; Golde,T. E.; Miele,L.; Foreman,K. E.Anticancer Research 2010 ;30(10):3853-3867

Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancerBurnell,M.; Levine,M. N.; Chapman,J. A.; Bramwell,V.; Gelmon,K.; Walley,B.; Vandenberg,T.; Chalchal,H.; Albain,K. S.; Perez,E. A.; Rugo,H.; Pritchard,K.; O'Brien,P.; Shepherd,L. E.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(1):77-82

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assaysAlbain,K. S.; Paik,S.; van't Veer,L.Breast 2009 ;18(Suppl 3):S141-5

Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339)Davies,A. M.; Chansky,K.; Lara,P. N.,Jr; Gumerlock,P. H.; Crowley,J.; Albain,K. S.; Vogel,S. J.; Gandara,D. R.; Southwest Oncology GroupJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009 ;4(1):87-92

Assessing breast cancer risk and providing treatment recommendations: immediate impact of an educational sessionGabram,S. G.; Dougherty,T.; Albain,K. S.; Klein,K.; Mumby,P.; Lee,K.; Yao,K.; Krishnamachari,B.; Salibay,C. J.; Lund,M. J.The breast journal 2009 ;15 Suppl 1( ):S39-45

International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapyCardoso,F.; Bedard,P. L.; Winer,E. P.; Pagani,O.; Senkus-Konefka,E.; Fallowfield,L. J.; Kyriakides,S.; Costa,A.; Cufer,T.; Albain,K. S.; ESO-MBC Task ForceJournal of the National Cancer Institute 2009 ;101(17):1174-1181

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trialAlbain,K. S.; Swann,R. S.; Rusch,V. W.; Turrisi,A. T.,3rd; Shepherd,F. A.; Smith,C.; Chen,Y.; Livingston,R. B.; Feins,R. H.; Gandara,D. R.; Fry,W. A.; Darling,G.; Johnson,D. H.; Green,M. R.; Miller,R. C.; Ley,J.; Sause,W. T.; Cox,J. D.Lancet 2009 ;374(9687):379-386

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trialAlbain,K. S.; Barlow,W. E.; Ravdin,P. M.; Farrar,W. B.; Burton,G. V.; Ketchel,S. J.; Cobau,C. D.; Levine,E. G.; Ingle,J. N.; Pritchard,K. I.; Lichter,A. S.; Schneider,D. J.; Abeloff,M. D.; Henderson,I. C.; Muss,H. B.; Green,S. J.; Lew,D.; Livingston,R. B.; Martino,S.; Osborne,C. K.Lancet 2009 ;374(9707):2055-2063

Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy SettingsLo,S. S.; Pritchard,K. I.; Robinson,P.; Albain,K. S.Cancer treatment and research 2009 ;147( ):1-29

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology GroupAlbain,K. S.; Unger,J. M.; Crowley,J. J.; Coltman,C. A.,Jr; Hershman,D. L.Journal of the National Cancer Institute 2009 ;101(14):984-992

Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897Ambrosone,C. B.; Barlow,W. E.; Reynolds,W.; Livingston,R. B.; Yeh,I. T.; Choi,J. Y.; Davis,W.; Rae,J. M.; Tang,L.; Hutchins,L. R.; Ravdin,P. M.; Martino,S.; Osborne,C. K.; Lyss,A. P.; Hayes,D. F.; Albain,K. S.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 ;27(30):4973-4979

Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A statusTubbs,R.; Barlow,W. E.; Budd,G. T.; Swain,E.; Porter,P.; Gown,A.; Yeh,I. T.; Sledge,G.; Shapiro,C.; Ingle,J.; Haskell,C.; Albain,K. S.; Livingston,R.; Hayes,D. F.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 ;27(24):3881-3886

Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancerChew,H. K.; Doroshow,J. H.; Frankel,P.; Margolin,K. A.; Somlo,G.; Lenz,H. J.; Gordon,M.; Zhang,W.; Yang,D.; Russell,C.; Spicer,D.; Synold,T.; Bayer,R.; Hantel,A.; Stiff,P. J.; Tetef,M. L.; Gandara,D. R.; Albain,K. S.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 ;27(13):2163-2169

Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trialChoi,J. Y.; Barlow,W. E.; Albain,K. S.; Hong,C. C.; Blanco,J. G.; Livingston,R. B.; Davis,W.; Rae,J. M.; Yeh,I. T.; Hutchins,L. F.; Ravdin,P. M.; Martino,S.; Lyss,A. P.; Osborne,C. K.; Abeloff,M. D.; Hayes,D. F.; Ambrosone,C. B.Clinical cancer research : an official journal of the American Association for Cancer Research 2009 ;15(16):5258-5266

Lung cancer outcomes in women.Shafer,D.; Albain,K.Seminars in oncology 2009 ;36(6):532-541

Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approachesRizzo,P.; Miao,H.; D'Souza,G.; Osipo,C.; Song,L. L.; Yun,J.; Zhao,H.; Mascarenhas,J.; Wyatt,D.; Antico,G.; Hao,L.; Yao,K.; Rajan,P.; Hicks,C.; Siziopikou,K.; Selvaggi,S.; Bashir,A.; Bhandari,D.; Marchese,A.; Lendahl,U.; Qin,J. Z.; Tonetti,D. A.; Albain,K.; Nickoloff,B. J.; Miele,L.Cancer research 2008 ;68(13):5226-5235

Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897Ganz,P. A.; Hussey,M. A.; Moinpour,C. M.; Unger,J. M.; Hutchins,L. F.; Dakhil,S. R.; Giguere,J. K.; Goodwin,J. W.; Martino,S.; Albain,K. S.Journal of Clinical Oncology 2008 ;26(8):1223-1230

Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment.Albain,K. S.; Nag,S. M.; Calderillo-Ruiz,G.; Jordaan,J. P.; Llombart,A. C.; Pluzanska,A.; Rolski,J.; Melemed,A. S.; Reyes-Vidal,J. M.; Sekhon,J. S.; Simms,L.; O'Shaughnessy,J.Journal of Clinical Oncology 2008 ;26(24):3950-3957

Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis.Camacho,P. M.; Dayal,A. S.; Diaz,J. L.; Nabhan,F. A.; Agarwal,M.; Norton,J. G.; Robinson,P. A.; Albain,K. S.Journal of Clinical Oncology 2008 ;26(33):5380-5385

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.Goodwin,J. W.; Green,S. J.; Moinpour,C. M.; Bearden,J. D.,3rd; Giguere,J. K.; Jiang,C. S.; Lippman,S. M.; Martino,S.; Albain,K. S.Journal of Clinical Oncology 2008 ;26(10):1650-1656

Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023Kelly,K.; Chansky,K.; Gaspar,L. E.; Albain,K. S.; Jett,J.; Ung,Y. C.; Lau,D. H.; Crowley,J. J.; Gandara,D. R.Journal of Clinical Oncology 2008 ;26(15):2450-2456

A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149).Swinnen,L. J.; Rankin,C.; Carraway,H.; Albain,K. S.; Townsend,J. J.; Budd,G. T.; Kish,J. A.; Rivkin,S. E.; Blumenthal,D. T.Journal of neuro-oncology 2008 ;86(3):353-358

Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence.Gotay,C. C.; Moinpour,C. M.; Unger,J. M.; Jiang,C. S.; Coleman,D.; Martino,S.; Parker,B. J.; Bearden,J. D.; Dakhil,S.; Gross,H. M.; Lippman,S.; Albain,K. S.Journal of Clinical Oncology 2007 ;25(15):2093-2099

New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survivalAmbrosone,C. B.; Rebbeck,T. R.; Morgan,G. J.; Albain,K. S.; Calle,E. E.; Evans,W. E.; Hayes,D. F.; Kushi,L. H.; McLeod,H. L.; Rowland,J. H.; Ulrich,C. M.Cancer Epidemiology, Biomarkers & Prevention 2006 ;15(11):2042-2046

Clinical factors used to support prophylactic mastectomy for a male BRCA2 mutation carrier.Guiahi,M.; Gabram,S. G.; Albain,K. S.; Camacho,P. M.; Krishnamachari,B.; Rajan,P.Surgery 2006 ;139(5):704-706

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.Robert,N.; Leyland-Jones,B.; Asmar,L.; Belt,R.; Ilegbodu,D.; Loesch,D.; Raju,R.; Valentine,E.; Sayre,R.; Cobleigh,M.; Albain,K.; McCullough,C.; Fuchs,L.; Slamon,D.Journal of Clinical Oncology 2006 ;24(18):2786-2792

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapyPorter,P. L.; Barlow,W. E.; Yeh,I. T.; Lin,M. G.; Yuan,X. P.; Donato,E.; Sledge,G. W.; Shapiro,C. L.; Ingle,J. N.; Haskell,C. M.; Albain,K. S.; Roberts,J. M.; Livingston,R. B.; Hayes,D. F.Journal of the National Cancer Institute 2006 ;98(23):1723-1731

Correlation of nipple aspiration and ductal lavage cytology with histopathologic findings for patients before scheduled breast biopsy examination.West,K. E.; Wojcik,E. M.; Dougherty,T. A.; Siziopikou,K. P.; Albain,K. S.; Gabram,S. G.American Journal of Surgery 2006 ;191(1):57-60

Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).Gandara,D. R.; Chansky,K.; Albain,K. S.; Gaspar,L. E.; Lara,P. N.,Jr; Kelly,K.; Crowley,J.; Livingston,R.Clinical Lung Cancer 2006 ;8(2):116-121

Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.Unger,J. M.; Coltman,C. A.,Jr; Crowley,J. J.; Hutchins,L. F.; Martino,S.; Livingston,R. B.; Macdonald,J. S.; Blanke,C. D.; Gandara,D. R.; Crawford,E. D.; Albain,K. S.Journal of Clinical Oncology 2006 ;24(1):141-144

Acute lung injury associated with vinorelbine.Tanvetyanon,T.; Garrity,E. R.; Albain,K. S.Journal of Clinical Oncology 2006 ;24(12):1952-1953

PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2.Albain,K. S.; Belani,C. P.; Bonomi,P.; O'Byrne,K. J.; Schiller,J. H.; Socinski,M.Clinical Lung Cancer 2006 ;7(6):417-419

Reducing the global breast cancer burden: the importance of patterns of care researchAlbain,K. S.; de la Garza Salazar,J.; Pienkowski,T.; Aapro,M.; Bergh,J.; Caleffi,M.; Coleman,R.; Eiermann,W.; Icli,F.; Pegram,M.; Piccart,M.; Snyder,R.; Toi,M.; Hortobagyi,G. N.Clinical Breast Cancer 2005 ;6(5):412-420

Multimodality therapy for stage III non-small-cell lung cancer.[erratum appears in J Clin Oncol. 2005 Oct 20;23(30):7763]Farray,D.; Mirkovic,N.; Albain,K. S.Journal of Clinical Oncology 2005 ;23(14):3257-3269

The global breast cancer burden: variations in epidemiology and survivalHortobagyi,G. N.; de la Garza Salazar,J.; Pritchard,K.; Amadori,D.; Haidinger,R.; Hudis,C. A.; Khaled,H.; Liu,M. C.; Martin,M.; Namer,M.; O'Shaughnessy,J. A.; Shen,Z. Z.; Albain,K. S.; ABREAST InvestigatorsClinical Breast Cancer 2005 ;6(5):391-401

Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology GroupGaspar,L. E.; Chansky,K.; Albain,K. S.; Vallieres,E.; Rusch,V.; Crowley,J. J.; Livingston,R. B.; Gandara,D. R.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 ;23(13):2955-2961

Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapyGandara,D. R.; Vallieres,E.; Gaspar,L. E.; Kelly,K.; Albain,K. S.; Herbst,R. S.,Jr; Lara,P. N.,Jr; Mack,P.; Gumerlock,P. H.; Crowley,J. J.Clinical Lung Cancer 2005 ;7 Suppl 3( ):S93-7

Current standards and ongoing controversies in the management of locally advanced non-small cell lung cancerWest,H.; Albain,K. S.Seminars in oncology 2005 ;32(3):284-292

Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancerPierce,L. J.; Hutchins,L. F.; Green,S. R.; Lew,D. L.; Gralow,J. R.; Livingston,R. B.; Osborne,C. K.; Albain,K. S.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 ;23(1):24-29

Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer : a realistic goal?Blackhall,F. H.; Shepherd,F. A.; Albain,K. S.Treatments in respiratory medicine 2005 ;4(2):71-84

Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxelEdelman,M. J.; Clark,J. I.; Chansky,K.; Albain,K.; Bhoopalam,N.; Weiss,G. R.; Giguere,J. K.; Kelly,K.; Crowley,J.; Gandara,D. R.Clinical cancer research : an official journal of the American Association for Cancer Research 2004 ;10(15):5022-5026

Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trialLara,P. N.,Jr; Gumerlock,P. H.; Mack,P. C.; Lau,D. H.; Gandour-Edwards,R.; Edelman,M. J.; Albain,K. S.; Law,L. Y.; Longmate,J.; Frankel,P.; Reddy,G. P.; Israel,V.; Doroshow,J. H.; Gandara,D. R.Clinical Lung Cancer 2004 ;6(2):102-107

The potential role of surgery after induction treatmentGrunenwald,D. H.; Albain,K. S.SEMINARS IN RADIATION ONCOLOGY 2004 ;14(4):335-339

Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulatorFabian,C. J.; Kimler,B. F.; Anderson,J.; Tawfik,O. W.; Mayo,M. S.; Burak,W. E.,Jr; O'Shaughnessy,J. A.; Albain,K. S.; Hyams,D. M.; Budd,G. T.; Ganz,P. A.; Sauter,E. R.; Beenken,S. W.; Grizzle,W. E.; Fruehauf,J. P.; Arneson,D. W.; Bacus,J. W.; Lagios,M. D.; Johnson,K. A.; Browne,D.Clinical cancer research : an official journal of the American Association for Cancer Research 2004 ;10(16):5403-5417

Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trialsAlbain,K. S.Journal of the National Cancer Institute 2004 ;96(24):1801-1804

Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504Gandara,D. R.; Chansky,K.; Albain,K. S.; Leigh,B. R.; Gaspar,L. E.; Lara,P. N.,Jr; Burris,H.; Gumerlock,P.; Kuebler,J. P.; Bearden,J. D.,3rd; Crowley,J.; Livingston,R.; Southwest Oncology GroupJournal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 ;21(10):2004-2010

Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR productsJuhasz,A.; Frankel,P.; Cheng,C.; Rivera,H.; Vishwanath,R.; Chiu,A.; Margolin,K.; Yen,Y.; Newman,E. M.; Synold,T.; Wilczynski,S.; Lenz,H. J.; Gandara,D.; Albain,K. S.; Longmate,J.; Doroshow,J. H.Journal of clinical laboratory analysis 2003 ;17(5):184-194

Induction treatment before surgery for non-small cell lung cancerEberhardt,W. E.; Albain,K. S.; Pass,H.; Putnam,J. B.; Gregor,A.; Assamura,H.; Mornex,F.; Senan,S.; Belderbos,J.; Westeel,V.; Thomas,M.; Van Schil,P.; Vansteenkiste,J.; Manegold,C.; Mirimanoff,R. O.; Stuschke,M.; Pignon,J.; Rocmans,P.; Shepherd,F. A.Lung cancer (Amsterdam, Netherlands) 2003 ;42 Suppl 1( ):S9-14

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancerHillner,B. E.; Ingle,J. N.; Chlebowski,R. T.; Gralow,J.; Yee,G. C.; Janjan,N. A.; Cauley,J. A.; Blumenstein,B. A.; Albain,K. S.; Lipton,A.; Brown,S.; American Society of Clinical OncologyJournal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 ;21(21):4042-4057

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trialKris,M. G.; Natale,R. B.; Herbst,R. S.; Lynch,T. J.,Jr; Prager,D.; Belani,C. P.; Schiller,J. H.; Kelly,K.; Spiridonidis,H.; Sandler,A.; Albain,K. S.; Cella,D.; Wolf,M. K.; Averbuch,S. D.; Ochs,J. J.; Kay,A. C.JAMA : the journal of the American Medical Association 2003 ;290(16):2149-2158

Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019Albain,K. S.; Crowley,J. J.; Turrisi,A. T.,3rd; Gandara,D. R.; Farrar,W. B.; Clark,J. I.; Beasley,K. R.; Livingston,R. B.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 ;20(16):3454-3460

Positive immunohistochemistry in histologically negative sentinel noeds: affect on adjuvant therapy in early-stage breast cancer.Stradling,B.; Albain,K.; Siziopikou,K.; Wilcoxson,L.; Aranha,G. V.; Shayani,V.; Fisher,S.; Grabram,S.Surgical Rounds 2002 ;25(11):535-542

Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trialsUnger,J. M.; Flaherty,L. E.; Liu,P. Y.; Albain,K. S.; Sondak,V. K.Cancer 2001 ;91(6):1148-1155

Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinomaClark,J. I.; Albain,K. S.Cancer treatment and research 2001 ;105( ):149-170

Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancerClark,J. I.; Kancharla,K.; Qamar,R.; Fisher,S.; Hantel,A.; Panganiban,J.; Millbrandt,L.; Albain,K. S.Lung cancer (Amsterdam, Netherlands) 2001 ;34(2):271-277

Induction chemotherapy or chemoradiotherapy before surgery for non-small-cell lung cancerAlbain,K. S.Current oncology reports 2000 ;2(1):54-63

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert PanelHillner,B. E.; Ingle,J. N.; Berenson,J. R.; Janjan,N. A.; Albain,K. S.; Lipton,A.; Yee,G.; Biermann,J. S.; Chlebowski,R. T.; Pfister,D. G.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 ;18(6):1378-1391

Behavioral science research in the cooperative group setting: the Southwest Oncology Group experienceGotay,C. C.; Moinpour,C. M.; Moody-Thomas,S.; Gritz,E. R.; Albain,K. S.; DeAntoni,E.; Hansen,L.; Ganz,P. A.Journal of the National Cancer Institute 2000 ;92(17):1381-1387

Education
Medical School
  • University of Michigan Medical School
Residency
  • University of Illinois at Chicago Medical Center, Internal Medicine: General
Fellowship
  • University of Chicago Hospitals and Clinics, Internal Medicine: Hematology & Medical Oncology
Interests
  • Classical Music
  • Travel
  • Family/Friends
  • Bicycling
  • Reading
  • Pipe Organ
  • Hiking
  • Singing
  • Exercise